FDA: B. Braun recalls blood administration sets

Editor's Note

The Food & Drug Administration (FDA) on November 26 announced a voluntary recall by B. Braun Medical (Bethlehem, Pennsylvania) of 22 lots of blood administration sets.

The recall was initiated because of the potential for leakage at the joint between the blood filters and tubing. This could force healthcare providers to connect a new blood administration set, delaying treatment, and the leak could allow microorganisms to enter the bloodstream and infect the patient, causing sepsis.

The blood administration sets were distributed between June 11, 2019 and September 27, 2019. To date there have been no reports of serious injuries or deaths.